Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Qsymia (phentermine/topiramate) and Ozempic (semaglutide) are both prescription medications that can help with weight management, but they have some important differences. Qsymia is a combination of a sympathomimetic and an antiepileptic, specifically approved for weight loss and long-term weight management in people living with obesity or are living with overweight and have at least one weight-related condition. Ozempic, on the other hand, is a GLP-1 agonist primarily approved for treating Type 2 diabetes and reducing the risk of heart problems in adults with this condition. While Ozempic is not FDA-approved for weight loss, it is sometimes used off-label for this purpose. Qsymia is taken by mouth once a day, while Ozempic is injected under the skin once a week. Qsymia is a controlled substance due to the phentermine component, whereas Ozempic is not. Common side effects of Qsymia include dry mouth and constipation, while Ozempic often causes nausea and diarrhea. Qsymia can cause a fast heart beat, while Ozempic can increase the risk of some types of thyroid cancers. Both medications can cause problems with vision.
Qsymia (phentermine / topiramate ER)
Ozempic (semaglutide)
Qsymia (phentermine / topiramate ER)
Ozempic (semaglutide)
Summary of Qsymia vs. Ozempic
Summary for Sympathomimetic / Antiepileptic
Prescription only
Qsymia (phentermine / topiramate extended release) is a combination medication used to help with weight loss. It's approved for people over 12 who are considered obese and for some adults who are considered overweight. This medication is a tablet that you take once a day. You should also eat a balanced diet and exercise regularly for best results. Side effects include a "pins-and-needles" feeling, dry mouth, and constipation. You can only get this medication through the Qsymia REMS (Risk Evaluation and Mitigation Strategies) program because of the risk of birth defects if taken during pregnancy.
Summary for GLP-1 agonist
Prescription only
Ozempic (semaglutide) is a prescription injection used with diet and exercise to help manage Type 2 diabetes in adults. It's also FDA approved to lower the risk of heart attack, stroke, and heart-related death in those with Type 2 diabetes and heart disease. In addition, it can reduce the risk of worsening kidney problems in people with Type 2 diabetes and chronic kidney disease (CKD). Ozempic (semaglutide) is a GLP-1 agonist that's injected under the skin once a week. Common side effects include nausea, vomiting, and diarrhea.
Indications of Qsymia vs. Ozempic
Indications for
•Weight loss and long-term weight management, together with diet and exercise, for certain people: